Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.8M
-
Number of holders
-
259
-
Total shares
-
12M
-
Shares change
-
+773K
-
Total reported value, excl. options
-
$751M
-
Value change
-
+$36.8M
-
Put/Call ratio
-
0.94
-
Number of buys
-
138
-
Number of sells
-
-116
-
Price
-
$62.41
Significant Holders of Fulgent Genetics, Inc. - Common Stock (FLGT) as of Q1 2022
276 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock as of Q1 2022.
Fulgent Genetics, Inc. - Common Stock (FLGT) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
of 30.8M outstanding shares and own 39.02% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.29M shares), VANGUARD GROUP INC (1.34M shares), STATE STREET CORP (696K shares), GEODE CAPITAL MANAGEMENT, LLC (376K shares), Pacer Advisors, Inc. (301K shares), Invesco Ltd. (297K shares), MILLENNIUM MANAGEMENT LLC (281K shares), Bank of New York Mellon Corp (250K shares), Park West Asset Management LLC (250K shares), and NORTHERN TRUST CORP (220K shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.